dc.creatorAlmeida, AA
dc.creatorCampos, DR
dc.creatorBernasconi, G
dc.creatorCalafatti, S
dc.creatorBarros, FAP
dc.creatorEberlin, MN
dc.creatorMeurer, EC
dc.creatorParis, EG
dc.creatorPedrazzoli, J
dc.date2007
dc.dateAPR 1
dc.date2014-11-17T12:34:56Z
dc.date2015-11-26T17:29:09Z
dc.date2014-11-17T12:34:56Z
dc.date2015-11-26T17:29:09Z
dc.date.accessioned2018-03-29T00:16:11Z
dc.date.available2018-03-29T00:16:11Z
dc.identifierJournal Of Chromatography B-analytical Technologies In The Biomedical And Life Sciences. Elsevier Science Bv, v. 848, n. 2, n. 311, n. 316, 2007.
dc.identifier1570-0232
dc.identifierWOS:000245762600019
dc.identifier10.1016/j.jchromb.2006.10.045
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/79551
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/79551
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/79551
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1285216
dc.descriptionA simple, sensitive and specific liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of memantine (1) in human plasma is presented. Sample preparation consisted of the addition of amantadine (11) as internal standard (IS), liquid-liquid extraction in basic conditions using a mixture of diethyl ether-chloroform (7:3, v/v) as extracting solvent, followed by centrifugation, solvent evaporation and sample reconstitution in methanol. Both I and 11 (internal standard) were analyzed using a C18 column and a mobile phase composed of methanol-water-formic acid (80:20:0.1, v/v/v). Eluted compounds were monitored using positive mode electrospray (ES) tandem mass spectrometry. The analyses were carried out by selected reaction monitoring (SRM) using the parent to daughter combinations of m/z 180 > 163 (memantine) and m/z 152 > 135 (amantadine). The peak areas from the analyte and IS were used for quantification of I. The achieved limit of quantification (LOQ) was 0.1 ng/mL; the assay exhibited a linear dynamic range of 0.1-50.0 ng/mL with a determination coefficient (r(2)) of at least 0.98. Validation results on linearity, specificity, accuracy, precision and stability, as well as on application to the analysis of samples taken up to 320 h after oral administration of 20 mg (two 10 mg capsules) of I in healthy volunteers demonstrated the applicability to bioequivalence studies. (c) 2006 Elsevier B.V. All rights reserved.
dc.description848
dc.description2
dc.description311
dc.description316
dc.languageen
dc.publisherElsevier Science Bv
dc.publisherAmsterdam
dc.publisherHolanda
dc.relationJournal Of Chromatography B-analytical Technologies In The Biomedical And Life Sciences
dc.relationJ. Chromatogr. B
dc.rightsfechado
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.sourceWeb of Science
dc.subjectmass spectrometry
dc.subjectbioequivalence
dc.subjectmemantine
dc.subjectValidation
dc.subjectUrine
dc.titleDetermination of memantine in human plasma by liquid chromatography-electrospray tandem mass spectrometry: Application to a bioequivalence study
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución